Diseases [C] » Urogenital Diseases [C12] » Female Urogenital Diseases and Pregnancy Complications » Female Urogenital Diseases » Genital Diseases, Female » Uterine Diseases » Uterine Hemorrhage
Diseases [C] » Urogenital Diseases [C12] » Genital Diseases » Genital Diseases, Female » Uterine Diseases » Uterine Hemorrhage
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Hemorrhage » Uterine Hemorrhage
Description
Bleeding from blood vessels in the UTERUS, sometimes manifested as vaginal bleeding. MeSH
Hierarchy View
Subtype Terms (3)
Menorrhagia
35 drugs (23 approved, 12 experimental)
Metrorrhagia
20 drugs (15 approved, 5 experimental)
Postpartum Hemorrhage
49 drugs (34 approved, 15 experimental)
Approved Indicated Drugs (5)
Phase 4 Indicated Drugs (6)
Phase 3 Indicated Drugs (6)
Phase 2 Indicated Drugs (2)
Other Experimental Indicated Drugs (2)
Organization Involved with Phase 4 Indications (13)
Organization Involved with Phase 3 Indications (11)
Organization Involved with Phase 2 Indications (9)
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (8)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
